IBDEI0R9 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12784,2)
 ;;=^5009018
 ;;^UTILITY(U,$J,358.3,12785,0)
 ;;=L03.011^^53^582^108
 ;;^UTILITY(U,$J,358.3,12785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12785,1,3,0)
 ;;=3^Cellulitis of Right Finger
 ;;^UTILITY(U,$J,358.3,12785,1,4,0)
 ;;=4^L03.011
 ;;^UTILITY(U,$J,358.3,12785,2)
 ;;=^5009019
 ;;^UTILITY(U,$J,358.3,12786,0)
 ;;=L03.012^^53^582^101
 ;;^UTILITY(U,$J,358.3,12786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12786,1,3,0)
 ;;=3^Cellulitis of Left Finger
 ;;^UTILITY(U,$J,358.3,12786,1,4,0)
 ;;=4^L03.012
 ;;^UTILITY(U,$J,358.3,12786,2)
 ;;=^5009020
 ;;^UTILITY(U,$J,358.3,12787,0)
 ;;=L03.021^^53^582^24
 ;;^UTILITY(U,$J,358.3,12787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12787,1,3,0)
 ;;=3^Acute Lymphangitis of Right Finger
 ;;^UTILITY(U,$J,358.3,12787,1,4,0)
 ;;=4^L03.021
 ;;^UTILITY(U,$J,358.3,12787,2)
 ;;=^5009022
 ;;^UTILITY(U,$J,358.3,12788,0)
 ;;=L03.022^^53^582^18
 ;;^UTILITY(U,$J,358.3,12788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12788,1,3,0)
 ;;=3^Acute Lymphangitis of Left Finger
 ;;^UTILITY(U,$J,358.3,12788,1,4,0)
 ;;=4^L03.022
 ;;^UTILITY(U,$J,358.3,12788,2)
 ;;=^5009023
 ;;^UTILITY(U,$J,358.3,12789,0)
 ;;=L03.031^^53^582^111
 ;;^UTILITY(U,$J,358.3,12789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12789,1,3,0)
 ;;=3^Cellulitis of Right Toe
 ;;^UTILITY(U,$J,358.3,12789,1,4,0)
 ;;=4^L03.031
 ;;^UTILITY(U,$J,358.3,12789,2)
 ;;=^5009025
 ;;^UTILITY(U,$J,358.3,12790,0)
 ;;=L03.032^^53^582^104
 ;;^UTILITY(U,$J,358.3,12790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12790,1,3,0)
 ;;=3^Cellulitis of Left Toe
 ;;^UTILITY(U,$J,358.3,12790,1,4,0)
 ;;=4^L03.032
 ;;^UTILITY(U,$J,358.3,12790,2)
 ;;=^5009026
 ;;^UTILITY(U,$J,358.3,12791,0)
 ;;=L03.041^^53^582^26
 ;;^UTILITY(U,$J,358.3,12791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12791,1,3,0)
 ;;=3^Acute Lymphangitis of Right Toe
 ;;^UTILITY(U,$J,358.3,12791,1,4,0)
 ;;=4^L03.041
 ;;^UTILITY(U,$J,358.3,12791,2)
 ;;=^5009028
 ;;^UTILITY(U,$J,358.3,12792,0)
 ;;=L03.042^^53^582^20
 ;;^UTILITY(U,$J,358.3,12792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12792,1,3,0)
 ;;=3^Acute Lymphangitis of Left Toe
 ;;^UTILITY(U,$J,358.3,12792,1,4,0)
 ;;=4^L03.042
 ;;^UTILITY(U,$J,358.3,12792,2)
 ;;=^5009029
 ;;^UTILITY(U,$J,358.3,12793,0)
 ;;=M34.0^^53^582^249
 ;;^UTILITY(U,$J,358.3,12793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12793,1,3,0)
 ;;=3^Progressive Systemic Sclerosis
 ;;^UTILITY(U,$J,358.3,12793,1,4,0)
 ;;=4^M34.0
 ;;^UTILITY(U,$J,358.3,12793,2)
 ;;=^5011778
 ;;^UTILITY(U,$J,358.3,12794,0)
 ;;=M34.1^^53^582^91
 ;;^UTILITY(U,$J,358.3,12794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12794,1,3,0)
 ;;=3^CR(E)ST Syndrome
 ;;^UTILITY(U,$J,358.3,12794,1,4,0)
 ;;=4^M34.1
 ;;^UTILITY(U,$J,358.3,12794,2)
 ;;=^5011779
 ;;^UTILITY(U,$J,358.3,12795,0)
 ;;=M34.2^^53^582^273
 ;;^UTILITY(U,$J,358.3,12795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12795,1,3,0)
 ;;=3^Systemic Sclerosis Induced by Drug/Chemical
 ;;^UTILITY(U,$J,358.3,12795,1,4,0)
 ;;=4^M34.2
 ;;^UTILITY(U,$J,358.3,12795,2)
 ;;=^5011780
 ;;^UTILITY(U,$J,358.3,12796,0)
 ;;=M34.81^^53^582^275
 ;;^UTILITY(U,$J,358.3,12796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12796,1,3,0)
 ;;=3^Systemic Sclerosis w/ Lung Involvement
 ;;^UTILITY(U,$J,358.3,12796,1,4,0)
 ;;=4^M34.81
 ;;^UTILITY(U,$J,358.3,12796,2)
 ;;=^5011781
 ;;^UTILITY(U,$J,358.3,12797,0)
 ;;=M34.82^^53^582^276
 ;;^UTILITY(U,$J,358.3,12797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12797,1,3,0)
 ;;=3^Systemic Sclerosis w/ Myopathy
 ;;^UTILITY(U,$J,358.3,12797,1,4,0)
 ;;=4^M34.82
 ;;^UTILITY(U,$J,358.3,12797,2)
 ;;=^5011782
